Genacol has been a leader in its field for more than 17 years.
BRUYERE Study
The first study was conducted over a six-month period at the University of Liège and included 200 subjects, aged 50 and over, who suffered from joint discomfort. The objective of the study was to demonstrate the efficacy of AminoLock® Collagen (1200 mg) in maintaining healthy joint*, as compared to a placebo.
To access to the results click on the link below
PARM Study
The second study was conducted at Veterans Memorial Medical Centre in the Philippines.
The objective of the study was to demonstrate the efficacy of AminoLock® Collagen in maintaining healthy joint* , as compared to a nonsteroidal anti-inflammatory drug. The study was conducted over a six-month period and included 113 patients.
If you want to see the result click the link below
SUAREZ Study
The third clinical study was conducted at the University of Santo Tomas Hospital in the Philippines.
The objective of the study was to determine the efficacy of AminoLock® Collagen, combined with physical exercise, in helping to maintain healthy joint*.
The placebo-controlled, triple-blind study included 109 subjects, aged 50 and older, who had experienced knee discomfort for over a month.
If you to see the results click on the link below
ConsumerLab.com
Recently, ConsumerLab.com, an independent organization that evaluates nutritional products in the USA, recognized Genacol’s clinical study as: ONE OF THE LARGEST STUDIES ABOUT COLLAGEN HYDROLYSATE.
The report also mentions that after 6 months of taking the collagen (Genacol) 51.6% of the participants reported a better joint health* (Bruyere, Comp Ther Med 2012)
